Company profile
Azure Biotech Inc.
Developing a novel product which addresses the unmet needs of postmenopausal women.
- Industry
- Biotechnology Research
- Employees
- 6
- Headquarters
- New York, NY
- Founded
- 2013
- Office locations
- 1
Azure Biotech Inc. company summary
Azure Biotech Inc. is a company in the Biotechnology Research industry, headquartered in New York, NY, founded in 2013. On LinkedIn the company has around 6 employees. Its listed specialties include Women's health and SERM.
What technology does Azure Biotech Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Azure Biotech Inc.
Azure Biotech, Inc. is a private, newly formed biotechnology company which has acquired rights for development of a novel formulation of lasofoxifene targeting an underserved market in women's health from Ligand Pharmaceuticals. The Azure team is uniquely qualified to bring lasofoxifene forward for targeted new indications and formulations. Azure plans to rapidly build upon the extensive safety and efficacy data already available from trials completed with an oral formulation in more than 15,000 women. The Company’s Board includes uniquely qualified seasoned experts, including Dr. David Thompson, a seasoned pharmaceutical executive who directed the Pfizer team in the discovery of oral lasofoxifene through Phase 3 development and regulatory filings, and two seasoned pharmaceutical executives with prior expertise in launching new ventures, Dr. Susan Levinson and Ms. Valerie Ceva. Dr. Steven R. Goldstein, MD, a globally recognized clinical leader in women’s health is Chair of the Scientific Advisory Board. Lasofoxifene is an estrogen partial agonist for osteoporosis treatment and other diseases that was discovered through the research collaboration between Ligand and Pfizer that began in 1991. The oral, 0.5 mg form of lasofoxifene tartrate was developed by Pfizer under the trade name Fablyn®, and progressed through regulatory approval in the EU. After Pfizer acquired Conbriza® (bazedoxifene), a similar SERM program, from its acquisition of Wyeth, rights to all forms of lasofoxifene reverted to Ligand in early 2011.
Specialties
Where is Azure Biotech Inc. located?
Azure Biotech Inc. lists 1 location.
Compare companies similar to Azure Biotech Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Azure Biotech Inc. azurebiotech.com | Biotechnology Research | 6 | 2013 | New York, NY |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Azure Biotech Inc.
What does Azure Biotech Inc. do?
Azure Biotech, Inc. is a private, newly formed biotechnology company which has acquired rights for development of a novel formulation of lasofoxifene targeting an underserved market in women's health from Ligand Pharmaceuticals. The Azure team is uniquely qualified to bring lasofoxifene forward for targeted new indications and formulations. Azure plans to rapidly build upon the extensive safety and efficacy data already available from trials completed with an oral formulation in more than 15,000 women. The Company’s Board includes uniquely qualified seasoned experts, including Dr. David Thompson, a seasoned pharmaceutical executive who directed the Pfizer team in the discovery of oral lasofoxifene through Phase 3 development and regulatory filings, and two seasoned pharmaceutical executives with prior expertise in launching new ventures, Dr. Susan Levinson and Ms. Valerie Ceva. Dr. Steven R. Goldstein, MD, a globally recognized clinical leader in women’s health is Chair of the Scientific Advisory Board. Lasofoxifene is an estrogen partial agonist for osteoporosis treatment and other diseases that was discovered through the research collaboration between Ligand and Pfizer that began in 1991. The oral, 0.5 mg form of lasofoxifene tartrate was developed by Pfizer under the trade name Fablyn®, and progressed through regulatory approval in the EU. After Pfizer acquired Conbriza® (bazedoxifene), a similar SERM program, from its acquisition of Wyeth, rights to all forms of lasofoxifene reverted to Ligand in early 2011.
How many employees does Azure Biotech Inc. have?
Azure Biotech Inc. has around 6 employees on LinkedIn.
Where is Azure Biotech Inc. headquartered?
Azure Biotech Inc. is headquartered in New York, NY.
When was Azure Biotech Inc. founded?
Azure Biotech Inc. was founded in 2013.
Build a lead list from companies like Azure Biotech Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.